Business payments firm Corpay Inc. said on Friday it was in talks with Alpha Group International about a possible cash offer for the UK-based financial services provider. Corpay, which offers tools that allow businesses...
Meiji, Lactalis, Saputo, Warburg may bid in Fonterra’s $2.4 billion sale, sources say
Companies including Japan’s Meiji, French group Lactalis and Canada’s Saputo are considering bidding for the units dairy giant Fonterra is seeking to divest, two sources with knowledge of the matter said...
J&J-backed HistoSonics explores sale at $2.5 billion valuation, FT reports
HistoSonics, a medical technology company backed by Johnson & Johnson, is exploring a potential sale at a valuation of more than $2.5 billion after receiving multiple takeover offers, the Financial Times reported on...
Equinor sells 60% stake in Brazil’s Peregrino field to Prio for $3.5 billion
Equinor Brasil Energia, a subsidiary of Norway’s Equinor, has agreed to sell its 60% operated interest in Brazil’s Peregrino oil field to Prio Tigris, a subsidiary of PRIO SA, for $3.5 billion, Equinor said...
Meiji, Lactalis, Saputo, Warburg may bid in Fonterra’s $2.4 billion sale, sources say
Companies including Japan’s Meiji, French group Lactalis and Canada’s Saputo are considering bidding for the units dairy giant Fonterra is seeking to divest, two sources with knowledge of the matter said...
Australia’s Platinum in talks to be swallowed up by L1 Capital
Australian fund manager Platinum Asset Management said on Thursday it was in talks with investment manager L1 Capital on a deal to create an A$18 billion ($12 billion) funds management group. While the financial terms...
Couche-Tard advances deal talks for Japan’s Seven & i with access to books
Alimentation Couche-Tard (ACT) and Japan’s Seven & I said they have signed a non-disclosure agreement (NDA) that will give the Canadian company access to the Japanese retailer’s financial data as it...
Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal
Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental drug to treat a life-threatening kidney disease. Under the deal terms, Novartis will pay $7...
GlobalData gets takeover proposals from funds managed by ICG, KKR
Britain’s GlobalData said on Wednesday it had received preliminary takeover proposals from funds managed by private equity groups ICG and KKR, sending its shares up as much as 35.9%. The data analytics and...
Pernod completes sale of wine portfolio to Accolade Wines owner
Pernod Ricard has completed the sale of its international wine portfolio, including brands like Jacob’s Creek, to Accolade Wines owner Australian Wine Holdco, it said on Wednesday. The transaction will result in...
Spain’s antitrust body clears BBVA-Sabadell takeover, awaits government
Spain’s competition watchdog CNMC approved on Wednesday the proposed acquisition of Banco Sabadell by its larger rival BBVA, though the combined lender will have to accept several remedies in its retail banking...
Blackstone explores $3 billion sale of sustainability software firm Sphera, sources say
Blackstone is exploring a $3 billion sale of Sphera, a sustainability software and consulting services provider, according to three people familiar with the matter. The private equity firm has hired investment bankers...
